Compare Aditya Birla Sun Life Pharma & Healthcare Fund vs SBI Healthcare Opportunities Fund
Aditya Birla Sun Life Pharma & Healthcare Fund
EquitySectoral-Pharma
SBI Healthcare Opportunities Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.31
1.99
NAV
₹33.54
₹477.03
Fund Started
20 Jun 2019
04 Jun 1999
Fund Size
₹1077.52 Cr
₹5870.00 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
6.85%
8.24%
3 Year
17.08%
20.22%
5 Year
11.67%
16.04%
Equity
97.94%
95.53%
Cash
2.06%
4.41%
Top 10 Holdings
Name | Assets |
|---|---|
Torrent Pharmaceuticals Ltd. | 9.28% |
Sun Pharmaceutical Industries Ltd. | 8.61% |
Apollo Hospitals Enterprise Ltd. | 6.44% |
Cipla Ltd. | 6.38% |
Aurobindo Pharma Ltd. | 4.52% |
Sai Life Sciences Ltd. | 4.49% |
Ajanta Pharma Ltd. | 4.35% |
Mankind Pharma Ltd. | 3.62% |
Dr. Lal Pathlabs Ltd. | 3.51% |
Abbott India Ltd. | 3.26% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.14% |
Divi's Laboratories Ltd. | 7.91% |
Acutaas Chemicals Ltd. | 5.03% |
Apollo Hospitals Enterprise Ltd. | 4.45% |
Torrent Pharmaceuticals Ltd. | 4.42% |
Cipla Ltd. | 4.40% |
Laurus Labs Ltd. | 4.05% |
Max Healthcare Institute Ltd. | 3.80% |
Aurobindo Pharma Ltd. | 3.42% |
Aster DM Quality Care Ltd. | 3.21% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
20 Jun 2019
04 Jun 1999
